chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized (4.1.22 - 4.7.22);  COVID-19 positive;  Fully vaccinated PLUS booster BRIEF OVERVIEW: Admission Date: 4/1/2022 Discharge Date: Apr 7, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation Acute respiratory failure with hypoxia  Acute hypoxemic respiratory failure  Pneumonia due to COVID-19 virus COVID HOSPITAL COURSE: 66 y.o. female with PMH significant for OSA on CPAP, history of lung cancer s/p chemo and radiation, COPD, type II DM, and HTN who presented to the ED for evaluation of 5 days of shortness of breath, wheezing, and cough. The patient is double vaccinated and boosted against COVID, and she had actually planned to get her 2nd booster shot next week.  The patient arrived in the ED hemodynamically stable, afebrile and hypoxic to 87% on room air. Hypoxia improved with 3 L nasal cannula. CBC was unremarkable. CMP was remarkable for Na 129, glucose 286, AST 92, ALT 38. BNP elevated to 1900. COVID 19 positive. CXR with new bilateral middle and bibasilar airspace opacities, right greater than left. EKG was obtained with sinus tachycardia. In the emergency department, the patient was given an albuterol nebulizer, a DuoNeb, and 125 mg IV Solu-Medrol. The patient was continued on decadron and supplemental oxygen with gradual improvement.  With the addition of steroids, patients blood sugar was very high requiring multiple doses of insulin. Evaluated by diabetes Service and recommended IV insulin gtt. She was eventually transitioned back to BBI at a lower dose than prior and was prescribed corrective insulin for while she is still on decadron. The patient was also noted to have a prolonged QTc. She was placed on tele and her electrolytes were optimized.  She continued to require 2-3L O2 for several days and was stable on 2L both at rest and with ambulation on day of discharge. Pulm rehab was consulted and arranged for home O2. Patient was also set up with COVID at home program. She was discharged on four days of decadron to complete 10 day course.
soreness @ site & deltoid area,then progressed to include neck & into eye;15OCT94 went to ER & was treated w/Motrin & DPH;to MD sometime later who took pt off meds because pt is on Pred for arthritis;was given unk type of med by MD;
This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore) and LIMB MASS (little painful lumps all over forearm and tender spots - on forearm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Drug allergy (paradoxical drug). Concurrent medical conditions included Drug allergy (seasonal allergies).    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing). At the time of the report, FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment included Tylenol, Claritin    This case was linked to MOD-2021-032621 (Patient Link).
Had hard lump on vaccination site; It was in verge of granuloma; Now there is a bruise; Hollowunderneath the skin of injection site, It was in verge of boil; It was very painful; They gave me a shot in my subcutaneous fat; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (Had hard lump on vaccination site), VACCINATION SITE GRANULOMA (It was in verge of granuloma), VACCINATION SITE BRUISING (Now there is a bruise), VACCINATION SITE REACTION (Hollowunderneath the skin of injection site, It was in verge of boil) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They gave me a shot in my subcutaneous fat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They gave me a shot in my subcutaneous fat). On 28-Apr-2021, the patient experienced VACCINATION SITE MASS (Had hard lump on vaccination site), VACCINATION SITE GRANULOMA (It was in verge of granuloma), VACCINATION SITE BRUISING (Now there is a bruise), VACCINATION SITE REACTION (Hollowunderneath the skin of injection site, It was in verge of boil) and VACCINATION SITE PAIN (It was very painful). On 27-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They gave me a shot in my subcutaneous fat) had resolved. At the time of the report, VACCINATION SITE MASS (Had hard lump on vaccination site), VACCINATION SITE GRANULOMA (It was in verge of granuloma), VACCINATION SITE BRUISING (Now there is a bruise), VACCINATION SITE REACTION (Hollowunderneath the skin of injection site, It was in verge of boil) and VACCINATION SITE PAIN (It was very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Patient felt sensation of being hot and heart racing, heart rate was 80 and pulse ox was 99%, denies resp symptoms, patient requested to go to ED to be evaluated, was seen in ED, observed, and discharged home
On 5/28 patient developed mid-sternal chest pain that woke him from sleep. Worse with position changes, some associated palpitations and shortness of breath. Came to ED, EKG consistent with acute pericarditis. No evidence of myocarditis on either labs (troponin 0.028) or echocardiogram (normal biventricular function). Discharged from ED with supportive care.
I was diagnosed with Shingles on Sept. 8., after days of itching and and burning feeling in my right are.
Ptn walked out of the immunization room and collapse in front of the pharmacy counter (About 25 feets). Maybe about 2-3 minutes after the shot. By the time I reach to her she was already awoken but unaware of surrounding. No head injury from the fall but did hit the knee on her way down.    Gave her some Orange Juice and she sat at the waiting area for about another 20 minutes.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. The pharmacist reported that on unspecified date, the patient might have been administered a dose of PROQUAD (dose, route of administration, lot# and expiration date were not reported) that was improperly stored (exposed to 82F). The vaccine was still out of range at the time of the call, so the total time out of range was unspecified. No adverse effects were reported. Additional information has been requested.
A nurse reported that a female resident of a long-term care facility received a dose of flu shield in November 2001. In January 2002, the resident developed a "severe" respiratory infection characterized by congestion and fever. A diagnosis of influenza A was confirmed by rapid antigen testing. She recovered. No further info was available at the date of this report.
Within 2 weeks after the 2nd shot the rash began on my torso. It then spread to my back, legs, arms and eventually my hands and feet. In July numbness happened in my feet and shoulders. I was not able to feel my feet or move my arms. In September the skin on my hands and feet began cracking and peeling. Walking and using my hands was nearly impossible. The symptoms resolve with steroids, however the exacerbation happen immediately after discontinuing use of the steroid. Severe itching. Skin feeling on fire causing chills. No fever. Causes blood pressure to increase.
had her booster about a month ago and right now she has shingles/ suspected vaccination failure; has shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, less than 2 months after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported for reporter's sister. The age at vaccination was not reported. The reporter stated the patient had her Shingles booster about a month ago of reporting and at the time of reporting had shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Client was seated on mother's lap during first attempt at vaccination.  Client moved and syringe came out of leg without administering any vaccine.  The syringe then fell to the floor.  A new dose was given in the opposite thigh without incident.
Patient scheduled appointment for the Moderna Bivalent Omicron Vaccine and was given the vaccine after she had already had the booster in October 2022.  No side effects I had her wait at the pharmacy and called her physician to notify and have her vaccine records updated properly.
Patient was admitted for pleuritic chest pain. It was determined during his hospitalization, that his pain was likely musculoskeletal in nature and was advised to follow up with PCP
DTP booster adm on 16APR91 in lt deltoid on 18APR91 pt c/o pain in arms, red oval "rash" fr site to lt elbow; Advised comfort measures & continue w/acetaminophen pain reliever;
3.0 cm induration with erythema locally. She also complained of pain for 72 hours, dull constant to left axilla.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-AUG-2016, the patient was vaccinated with a dose of improperly stored of PROQUAD (lot # M010478, expiration date: 01-SEP-2017; dose and route were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Approximately 38 hrs after administration of MENACTRA and HPV vacc, pt developed and was woken by "severe" headache, T 102 degrees, jaw/hand/neck pain.  Pt w/ hx URA.  Rx ibuprofen.  Joint pain improved in < 48 hours fever decrease in < 48 hours.
Information has been received from a physician concerning a 78-year-old female with no allergies or pertinent medical history who on 21-NOV-2007 was vaccinated subcutaneously with a 0.65 milliliter dose of zoster vaccine live (Oka/Merck). There was no concomitant medication. On 23-NOV-2007 the patient developed "significant headaches that were generalized". The patient contacted the physician for medical attention. No laboratory tests or diagnostic studies were performed. The outcome was reported as recovering, " the headaches got less severe but are not completely resolved". No product quality complaint was involved. Additional information has been requested.
Headache; Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CP7534) via an unspecified route of administration in the left arm on 18Mar2021 at 16:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, blood pressure high (bp/high), cholesterol and herniated disc. The patient did not receive any medication within two weeks of vaccination. The patient received concomitant medications within two weeks of vaccination, but were unspecified. The patient previously received cefdinir (OMNICEF) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 17:45, within an hour of vaccine, the patient had a severe headache and ears started ringing. The headache went away by next morning but ears were still ringing almost two months later. Therapeutic measured were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 23Apr2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the event headache was resolved on 19Mar2021 while that of ringing in ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Blood in the urine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Blood in the urine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (Blood in the urine). At the time of the report, BLOOD URINE PRESENT (Blood in the urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medications were not provided by the reporter   Reporter did not allow further contact
sweating; in bed a lot over the last 6 days; shakes; Vomiting; Huge headache; Very fatigued; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), MALAISE (in bed a lot over the last 6 days), TREMOR (shakes), VOMITING (Vomiting) and HEADACHE (Huge headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), MALAISE (in bed a lot over the last 6 days), TREMOR (shakes), VOMITING (Vomiting), HEADACHE (Huge headache), FATIGUE (Very fatigued), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Mar-2021, VOMITING (Vomiting) had resolved. On 30-Mar-2021, HYPERHIDROSIS (sweating), MALAISE (in bed a lot over the last 6 days), TREMOR (shakes), HEADACHE (Huge headache), FATIGUE (Very fatigued), PYREXIA (fever) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 103f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Within 6 hours of my first Pfizer vaccine, I felt out-of-body & almost "high" for 2-3 days.  I almost felt like I was in twilight, didn't feel safe to drive, or do much at all.  Within 2 days of the first vaccine, I started having "restless leg syndrome" sensation but over my entire body.  My body was constantly moving, I had no relief and it kept me up for a few nights.  I would say this sensation lasted about a week, in addition to my heart-racing.  I cried just about every night for two weeks because of the unnatural feelings this vaccine caused me; I feared what was going to come next since the beginning was already not so great.
uncomfortable while walking; pain in knees, really bad; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (uncomfortable while walking) and ARTHRALGIA (pain in knees, really bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included PREDNISONE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced GAIT DISTURBANCE (uncomfortable while walking) and ARTHRALGIA (pain in knees, really bad). On 12-Mar-2021, ARTHRALGIA (pain in knees, really bad) had resolved. At the time of the report, GAIT DISTURBANCE (uncomfortable while walking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Narrative: Patient is a 45-year-old male who presented to walk-in clinic to obtain medical clearance for second Moderna COVID-19 vaccine dose. Per patient's report, his first dose was on 4/2/21, and he had no instantaneous events. However, while at work approximately  1 hour after injection of vaccine, he became lightheaded/dizzy, and experienced throat swelling, tightness and difficulty swallowing. He also had shortness of breath with labored breathing. After 30 minutes of rest, his symptoms resolved, except for fatigue, but he was able to return to work
intermittent screaming episodes assoc w/staring behavior-stiff extremities each episodes lasted a few moments;exact length unk but occurred every 30min for 1 day then gradually resolved in 2 more days;
A rash developed on the left side of leg where vaccine was administered.  The rash looked very similar to a chicken pox rash and spread on the outside of leg from hip to knee.  The rash consisted of about 50 vesicle "pox looking" bumps and it lasted for over two weeks after the vaccine was given.  The rash did not spread anywhere else on child's body and was only located on the leg of the vaccine.
punctured vial after its been stored for more than 24 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (punctured vial after its been stored for more than 24 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (punctured vial after its been stored for more than 24 hours). On 19-May-2021, EXPIRED PRODUCT ADMINISTERED (punctured vial after its been stored for more than 24 hours) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information were not provided.
Received vaccines 11/29/10 reaction started 11/30/10 red raised 3 inch lump sore warm to touch.
This spontaneous report was received from a 76 year old patient regarding herself. On an unknown date in 2008 (reported as 5 years ago) the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and route was not reported). On an unknown date in March, the patient noticed a rash on the right side of her stomach which lasted for a month and for few months every so many days the patient felt heat in her face, arms and body which would last for about twenty minutes. The patient stated it happened 8 times last month not at all. The outcome of the events were unknown. Additional information is not expected.
Lump raised and progressively spread, red warm painful, approximately 8pm consulted with a pharmacist took BENADRYL and ZYRTEC, burning sensation across chest stomach thighs redness continued to spread along with pain in forearm approximately 5pm visited urgent care on 11/5/16 6cm by 6cm reaction of redness in addition to swelling and pain prescribed PEPCID in addition to BENADRYL And ZYRTEC severe headache began 11/7/16 continued pain muscle ache weakness, chills  headache 11/9/16 followed up with Dr prescribed mobid and SUDAFED swelling still present but mild still pain and weakness in arm and fluid ears, chills.